SuperworthHeartSciences EPS HSCS
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Oct 31, 2025
- −$6.95
- Latest quarter, Q2 FY26
- −$0.85
- Fiscal year 2025
- −$9.43
HeartSciences' earnings per share was −$6.95 over the twelve months to Oct 31, 2025.
In its latest quarter, Q2 FY26, it was −$0.85.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$9.43 | n/a |
| FY2024 | −$34.96 | n/a |
| FY2023 | −$83.00 | n/a |
| FY2022 | −$145.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.85 | n/a | −$6.95 | |
| Q1 FY26 | −$1.58 | n/a | −$8.37 | |
| Q4 FY25 | −$1.95 | n/a | −$9.43 | |
| Q3 FY25 | −$2.57 | n/a | −$10.28 | |
| Q2 FY25 | −$2.27 | n/a | −$10.72 | |
| Q1 FY25 | −$2.64 | n/a | −$24.37 | |
| Q4 FY24 | −$2.80 | n/a | −$34.96 | |
| Q3 FY24 | −$3.01 | n/a | −$49.16 | |
| Q2 FY24 | −$15.92 | n/a | −$62.15 | |
| Q1 FY24 | −$13.23 | n/a | −$68.23 | |
| Q4 FY23 | −$17.00 | n/a | −$83.00 | |
| Q3 FY23 | −$16.00 | n/a | −$128.00 |
Against its peers
Companies in Financial - Credit Services nearest HeartSciences' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| HSCSHeartSciences | n/m | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| ATCHAtlasClear | $0.01 | |
| RSSSResearch Solutions | $0.09 | +200% a year |
| MACIMelar Acquisition Corp. I/Cayman | $0.17 | |
| Peer median | $0.09 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on HeartSciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.